GL1X · GenesisL1 explorer

MolNFT v1 · #134767 · protein

Tev cleaved human ATP citrate lyase bound to citrate and ADP

5TES · ATP-citrate synthase: “Tev cleaved human ATP citrate lyase bound to citrate and ADP”. X-ray diffraction, 2 ligands (ADP, MG), 8 pockets (best druggability 0.81). MolNFT v1 #134767 on GenesisL1: 3D structure, binding sites and…

PDB
5TES
Type
protein
Length
749 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ATP-citrate synthase
EC
2.3.3.8
UniProt
P53396
Ligands
ADP, MG
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AATP-citrate synthase (EC 2.3.3.8)protein42535% helix, 25% strandP53396
BATP-citrate synthase (EC 2.3.3.8)protein32436% helix, 20% strandP53396

Ligands and binding sites

  • ADP · Adenosine-5'-diphosphate · ligand · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • FLC · Citrate anion · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15920.810.8775FLC, MG
23260.720.8550MG, ADP
32120.610.8231empty
4780.520.8521empty
51170.480.8023empty

Interfaces

1 interface between chains.

  • A–B · 2286 Ų buried · 40 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 5TES · TEV Cleaved Human ATP Citrate Lyase Bound to Citrate and ADP · the same entry in another collection · chain A against A, TM-score 1.00
  • P53396 · AlphaFold monomer V2.0 prediction for ATP-citrate synthase (P53396) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.